Celldex Therapeutics
CLDX
CLDX
228 hedge funds and large institutions have $2.31B invested in Celldex Therapeutics in 2026 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 67 increasing their positions, 58 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
16% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 58
1.19% less ownership
Funds ownership: 110.21% → 109.02% (-1.2%)
38% less call options, than puts
Call options by funds: $3.79M | Put options by funds: $6.1M
Holders
228
Holding in Top 10
9
Calls
$3.79M
Puts
$6.1M
Top Buyers
| 1 | +$40.1M | |
| 2 | +$13.1M | |
| 3 | +$12.6M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.1M |
| 5 |
EP
Eversept Partners
New York
|
+$9.63M |
Top Sellers
| 1 | -$65.9M | |
| 2 | -$31.6M | |
| 3 | -$27.4M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$16.8M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$16.5M |
